Your blueprint is written in your blood: how you handle glucose, how your thyroid is performing, where your inflammation sits, what your hormones are actually up to.
Physician-led · Bloodwork first · Evidence-driven
What we do
Before considering peptides it is important to understand what your bloodwork reveals about your current health status. This is where the process begins.
Baseline panels, metabolic markers, organ function, thyroid, the growth axis, inflammation. Ordered through a licensed physician, run by an accredited lab.
A physician reads your results against your history and your goals. Not a reference range printout, an actual interpretation of what your numbers mean for you.
A game plan built from what your blueprint shows. Sometimes that involves a compound and a prescriber. Often it starts with iron, thyroid, or sleep.
The same panels repeated at the right interval, compared directly against your baseline. You find out whether anything actually changed, or whether you just felt like it did.
The evidence ledger
Two questions get constantly confused: is it legal, and does it work. A compound can be perfectly legal and useless, or promising and prohibited. We grade them separately, 62 compounds across eight categories.
Weight, glucose, and body composition.
Explore 13Growth hormone axis and muscle.
Explore 10Healing, connective tissue, inflammation.
Explore 6Longevity and cellular research.
Explore 4Skin, hair, pigmentation.
Explore 5Memory, mood, sleep.
Explore 7These are mostly real prescription drugs.
Explore 3Immune and respiratory research.
ExploreBefore you read the ledger
Fifty-one amino acids in two chains. It turned a fatal diagnosis into a managed condition a century ago, and it was the first peptide drug ever made. So is Ozempic. So is roughly a hundred other approved medicines. The scepticism on this site is aimed at specific unproven compounds. Not at the field, which has an extraordinary record when the work actually gets done.
More than a hundred peptide therapeutics have full regulatory approval worldwide, spanning diabetes, cancer, hormonal disorders and rare disease. Over a thousand more are in clinical development.
Mean weight loss reported in retatrutide's Phase 3 programme at 80 weeks, territory previously reachable only through surgery. Whatever its legal status, that result is real and it changes expectations.
The first genuine human randomised trial of BPC-157 began recruiting in April. After years of argument conducted entirely on preclinical data, the question is finally being asked properly.
Six peptides received favourable advisory recommendations in July 2026. If FDA follows through on rulemaking, compounds currently only available through the grey market get a regulated, prescribed route for the first time.
Start here
Every inquiry is read by a person and gets a real answer. If what you are asking about is not supported by evidence, or is not legally available to you, we will say so.
No cost, no card, no obligation. Consultations are currently available to California residents, and we answer email from anywhere.
Free, no obligation
Every inquiry gets a real answer from a person. If what you're asking about isn't supported by evidence, we'll say so.